港股異動 | 年度利潤超預期 普拉達盤初大升13%創階段新高
普拉達(1913.HK)盤初一度衝高至13%,高見62.9港元刷新階段新高,總市值1568億港元。公司23年取得收益淨額47.26億歐元,按固定匯率計,同比增加17.2%;經調整EBIT10.62億歐元,同比增加25.62%;該集團收入淨額6.71億歐元,同比增加44.25%;擬派發股息每股0.137歐元。中金公司點評稱,公司2023利潤超過市場一致預期,在2024年頭兩個月,集團銷售勢頭與4Q23類似,中國遊客於歐洲消費已恢復至疫情前70-80%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.